advisorsecurities master

ESLAEstrella Immunopharma, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
14923
Ticker
ESLA
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2023-10-02
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ESLA

Detail

Enriched 2026-08-14 20:47

Market cap
$31,849,632.14
Shares outstanding (class)
43,034,228
Shares outstanding (weighted)
43,034,228
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
Location
EMERYVILLE, CA
Description

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data